This microlearning explores the practical management of iron deficiency, focusing on navigating the transition from oral to intravenous therapy and understanding the biological drivers of treatment failure. Through a real-world clinical case, you will evaluate the indications for IV iron—such as oral intolerance and the need for rapid repletion—while examining the “hepcidin revolution” and how this master regulatory hormone influences iron absorption and patient adherence.
Optimizing Iron Therapy: Oral, Intravenous, and the Hepcidin Revolution
CAN-eng
$0
free
Unaccredited
5 min
Haematology
0 Credits
Course Description
Course Details
Expiry Date: 2027-02-10
Professions: Physician, Nursing, Pharmacy, Allied Health, Medical Resident, Student, Specialist
Faculty
Accreditation
Learning Objective(s)
After viewing this microlearning, participants will be better able to:
-
Evaluate the clinical indications for transitioning from oral to intravenous iron therapy based on patient tolerance, deficiency severity, and the need for rapid repletion.
-
Explain the regulatory role of hepcidin in iron homeostasis and its impact on the efficacy of oral supplementation and patient adherence.